Preoperative Continuation of RAAS Inhibitors in Hypertensive Patients Undergoing Noncardiac Surgery
Withholding RAASi prior to noncardiac operation significantly reduced the risk of intraoperative hypotension but may increase the chance to develop POAF without significant impact on 30-day mortality and other postoperative complications. Discontinuation of RAASi before noncardiac surgery is recommended unless obligate indication.
Authors
- Tanattha Kittisopee (ORCID: https://orcid.org/0000-0002-5240-8265)
- Bunchai Chongmelaxme (ORCID: https://orcid.org/0000-0002-7750-6961)
- Sarawut Siwamogsatham (ORCID: https://orcid.org/0000-0001-5747-6585)
- Su Myat Thin (ORCID: https://orcid.org/0000-0002-9771-7408)
- Myo Thiha Zaw
- Osot Nerapusee (ORCID: https://orcid.org/0000-0001-8919-0063)
Institutions
- Siam University (TH)
- Chulalongkorn University (TH)
- St James's University Hospital (GB)
- Revolution Research (US)
- Eastern Asia University (TH)
- Rangsit University (TH)
Publication Details
- Journal
- American Journal of Hypertension
- Published
- 2025-08-27
- DOI
- https://doi.org/10.1093/ajh/hpaf171
- Citations
- 1
- Primary Topic
- Cardiac, Anesthesia and Surgical Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 1.39